To protect or adversely affect? The dichotomous role of the NLRP1 inflammasome in human disease
Open Access
- 1 December 2020
- journal article
- review article
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 76, 100858
Abstract
No abstract availableKeywords
Funding Information
- Virginia Polytechnic Institute and State University
This publication has 166 references indexed in Scilit:
- Anthrax and the inflammasomeMicrobes and Infection, 2012
- Anthrax lethal toxin activates the inflammasome in sensitive rat macrophagesBiochemical and Biophysical Research Communications, 2010
- Fine-Mapping of Vitiligo Susceptibility Loci on Chromosomes 7 and 9 and Interactions with NLRP1 (NALP1)Journal of Investigative Dermatology, 2010
- The InflammasomesCell, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Vaccinia virus–specific molecular signature in atopic dermatitis skinJournal of Allergy and Clinical Immunology, 2010
- The Pannexin 1 Channel Activates the Inflammasome in Neurons and AstrocytesJournal of Biological Chemistry, 2009
- Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2009
- A NOD2–NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptideProceedings of the National Academy of Sciences, 2008
- Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptorThe EMBO Journal, 2006